Fig. 2
From: Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma
Changes in serum inflammatory markers within 1 month after ET019003 infusion. A Fold changes of inflammatory cytokines from baseline to peak (n = 10). Patient 5 received the repeated infusions in the outpatient department and data were not available. B–I Changes in the serum interleukin (IL)-6, C-reactive protein (CRP), IL-2, IL-4, IL-10, interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α) and ferritin in individuals. J Changes in serum IL-6, CRP, and ET019003 counts and copies in peripheral blood (PB) of patient 2, 4 and 8